POMALYST® (pomalidomide) Logo

This site is intended for US audiences only.

POMALYST is a prescription medicine, taken along with the medicine dexamethasone, used to treat adults with multiple myeloma who have previously received at least 2 medicines to treat multiple myeloma, including a proteasome inhibitor and lenalidomide, and whose disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and effective in children.

The REMS Companion App

Easily access the POMALYST REMS® program.

Download now

Real patients tell their treatment stories

Laurie, a former POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma
Laurie, a former POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma

Laurie and her caregiver Nowell share their experience with POMALYST.

WATCH NOW

Laurie is no longer taking POMALYST. Laurie and Nowell were compensated for their time by Celgene Corporation, a Bristol Myers Squibb company.

Marc, a current POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma
Marc, a current POMALYST® (pomalidomide) patient with relapsed/refractory multiple myeloma

Marc and his caregiver Michele talk about using POMALYST.

WATCH NOW

Marc is currently taking POMALYST. Marc and Michele were compensated for their time by Celgene Corporation, a Bristol Myers Squibb company.

Access & Financial Resources

Depending on your insurance situation, there are programs and organizations that may help pay for POMALYST.

LEARN MORE

Patient Resources

Access tools to help you learn about multiple myeloma.

EXPLORE RESOURCES

This website is best viewed
using the horizontal display
on your tablet device.

This website is best viewed
using the vertical display
on your mobile device.